The Felsher Lab current members
Life Science Research Professional/Laboratory Manager
Working on translational projects and industry collaborations, in addition to laboratory management.
Research Professional/Mouse Colony
Oversee Felsher Lab transgenic mice colony.
Jangho (Jason) Park
Working with Renu Dhanasekaran on the characterization and synthesis of nanoparticles for delivery of immuno-modulating agents to tumors.
Instructors and Research Associates
Ling Tong, PhD
Utilizing intravital microscopy to interrogate the impact of MYC inhibition on tumor maintenance and regression.
Jingjin Wang, MD PhD
Studying the anti-tumor effect of the small molecular compounds and related mechanisms.
Renu Dhanasekaran, MD
Pursuing basic and translational research in the field of hepatobiliary malignancies. The overall goal of my research is to identify biologically relevant prognostic biomarkers and molecular targets for drug therapy and consequently improve the clinical outcome of patients with hepatocellular carcinoma (HCC).
Aida Solhoej Hansen, PhD
I am interested is in how extracellular vesicles are utilized to shape the function of immune cells. I am studying how cancer-cell intrinsic events may affect the secretion and function of extracellular vesicles as a mechanism to modulate the immune cells in the tumor microenvironment.
Wadie Daniel Mahuad Fernandez, PhD
Define the mechanisms of apoptosis, senescence, and growth inhibition in Myc-driven cancers using both genetic and pharmacological approaches bridging basic science research to translational research.
Arvin Gouw, PhD
Investigating the metabolic mechanisms of oncogene addiction.
Anja Deutzmann, PhD
Utilizing PET-imaging and intravital microscopy to interrogate the impact of MYC inhibition on tumor maintenance and regression.
Christina Kim Lee, PhD
Delineating the role of oncogene MYC on immune cell polarization and function.
Maya Shraddha Krishnan
Identifying and investigating biomarkers of hepatocellular carcinoma (HCC).
Fidelia Beatrice Alvina
Investigating the mechanism of action of natural products and cancer metabolic disruption in causing cancer regression (HCC).